FI20070853A0 - Glykanbindande monoklonala antikroppar - Google Patents

Glykanbindande monoklonala antikroppar

Info

Publication number
FI20070853A0
FI20070853A0 FI20070853A FI20070853A FI20070853A0 FI 20070853 A0 FI20070853 A0 FI 20070853A0 FI 20070853 A FI20070853 A FI 20070853A FI 20070853 A FI20070853 A FI 20070853A FI 20070853 A0 FI20070853 A0 FI 20070853A0
Authority
FI
Finland
Prior art keywords
monoclonal antibodies
glycan binding
binding monoclonal
glycan
antibodies
Prior art date
Application number
FI20070853A
Other languages
English (en)
Finnish (fi)
Inventor
Marja-Leena Laukkanen
Kristiina Takkinen
Jari Natunen
Tero Satomaa
Jaakko Parkkinen
Leena Valmu
Sari Tiitinen
Original Assignee
Glykos Finland Oy
Suomen Punainen Risti Veripalv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glykos Finland Oy, Suomen Punainen Risti Veripalv filed Critical Glykos Finland Oy
Priority to FI20070853A priority Critical patent/FI20070853A0/sv
Publication of FI20070853A0 publication Critical patent/FI20070853A0/sv
Priority to US12/741,987 priority patent/US20100292095A1/en
Priority to AU2008324073A priority patent/AU2008324073A1/en
Priority to JP2010532633A priority patent/JP2011504099A/ja
Priority to CA2743032A priority patent/CA2743032A1/en
Priority to EP08847066A priority patent/EP2209809A4/en
Priority to PCT/FI2008/050643 priority patent/WO2009060129A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3076—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells against structure-related tumour-associated moieties
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI20070853A 2007-11-09 2007-11-09 Glykanbindande monoklonala antikroppar FI20070853A0 (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FI20070853A FI20070853A0 (sv) 2007-11-09 2007-11-09 Glykanbindande monoklonala antikroppar
US12/741,987 US20100292095A1 (en) 2007-11-09 2008-11-10 Human monoclonal antibodies directed to sialyl lewis c, sialyl tn and n glycolylneuraminic acid epitopes and a method of analysis of stem cells comprising said epitopes
AU2008324073A AU2008324073A1 (en) 2007-11-09 2008-11-10 Human monoclonal antibodies directed to sialyl Lewis c, sialyl Tn and N-glycolylneuraminic acid epitopes and a method of analysis of stem cells comprising said epitopes
JP2010532633A JP2011504099A (ja) 2007-11-09 2008-11-10 シアリルルイスｃ、シアリルＴｎ、及びＮ−グリコリルノイラミン酸のエピトープに関連づけられるヒトモノクローナル抗体、ならびに前記エピトープを含む幹細胞の分析方法
CA2743032A CA2743032A1 (en) 2007-11-09 2008-11-10 Human monoclonal antibodies directed to sialyl lewis c, sialyl tn and n-glycolylneuraminic acid epitopes and a method of analysis of stem cells comprising said epitopes
EP08847066A EP2209809A4 (en) 2007-11-09 2008-11-10 HUMAN MONOCLONAL ANTIBODIES AGAINST SIALYLE LEWIS C, SIALYLE TN AND N-GLYCOLYLNEURAMINIC EPITOPES AND STEM CELL ANALYSIS METHOD COMPRISING SAID EPITOPES
PCT/FI2008/050643 WO2009060129A1 (en) 2007-11-09 2008-11-10 Human monoclonal antibodies directed to sialyl lewis c, sialyl tn and n-glycolylneuraminic acid epitopes and a method of analysis of stem cells comprising said epitopes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20070853A FI20070853A0 (sv) 2007-11-09 2007-11-09 Glykanbindande monoklonala antikroppar

Publications (1)

Publication Number Publication Date
FI20070853A0 true FI20070853A0 (sv) 2007-11-09

Family

ID=38786638

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20070853A FI20070853A0 (sv) 2007-11-09 2007-11-09 Glykanbindande monoklonala antikroppar

Country Status (7)

Country Link
US (1) US20100292095A1 (sv)
EP (1) EP2209809A4 (sv)
JP (1) JP2011504099A (sv)
AU (1) AU2008324073A1 (sv)
CA (1) CA2743032A1 (sv)
FI (1) FI20070853A0 (sv)
WO (1) WO2009060129A1 (sv)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20095418A0 (sv) * 2009-04-16 2009-04-16 Suomen Punainen Risti Veripalv Kryptisk subpopulation
US8452875B2 (en) * 2008-10-13 2013-05-28 Mitsubishi Electric Corporation Resource allocation apparatus, resource allocation program and recording media, and resource allocation method
WO2013151649A1 (en) * 2012-04-04 2013-10-10 Sialix Inc Glycan-interacting compounds
ES2668045T3 (es) 2012-12-07 2018-05-16 Glycomimetics, Inc. Compuestos, composiciones y métodos que usan antagonistas de la E-selectina para la movilización de las células hematopoyéticas
PT3218005T (pt) 2014-11-12 2023-04-11 Seagen Inc Compostos que interagem com glicano e métodos de uso
US9879087B2 (en) 2014-11-12 2018-01-30 Siamab Therapeutics, Inc. Glycan-interacting compounds and methods of use
ES2754549T3 (es) 2014-12-03 2020-04-20 Glycomimetics Inc Inhibidores heterobifuncionales de E-selectinas y receptores de quimioquinas CXCR4
EP3371222A1 (en) * 2015-11-03 2018-09-12 GlycoMimetics, Inc. Methods and compositions for the production of monoclonal antibodies, hematopoietic stem cells, and methods of using the same
SG11201803213XA (en) 2015-11-12 2018-05-30 Siamab Therapeutics Inc Glycan-interacting compounds and methods of use
WO2017151708A1 (en) 2016-03-02 2017-09-08 Glycomimetics, Inc. Methods for the treatment and/or prevention of cardiovescular disease by inhibition of e-selectin
EP3497131B1 (en) 2016-08-08 2022-03-09 GlycoMimetics, Inc. Combination of t-cell checkpoint inhibitors with inhibitors of e-selectin or cxcr4, or with heterobifunctional inhibitors of both e-selectin and cxcr4.
EP3522931A1 (en) 2016-10-07 2019-08-14 GlycoMimetics, Inc. Highly potent multimeric e-selectin antagonists
WO2018094143A1 (en) 2016-11-17 2018-05-24 Siamab Therapeutics, Inc. Glycan-interacting compounds and methods of use
GB201703212D0 (en) * 2017-02-28 2017-04-12 Nat Univ Ireland Galway The detectionm quantification and discrimination of the sialic acid N-glycolylneuraminic (Neu5Gc) acid and N-acetylneuraminic acid (Neu5gc)
KR20240044544A (ko) 2017-03-03 2024-04-04 씨젠 인크. 글리칸-상호작용 화합물 및 사용 방법
JP7272956B2 (ja) 2017-03-15 2023-05-12 グリコミメティクス， インコーポレイテッド Ｅ－セレクチンアンタゴニストとしてのガラクトピラノシル－シクロヘキシル誘導体
JP7275131B2 (ja) 2017-11-30 2023-05-17 グリコミメティクス， インコーポレイテッド 骨髄浸潤リンパ球を動員する方法、およびその使用
EP3732186A1 (en) 2017-12-29 2020-11-04 GlycoMimetics, Inc. Heterobifunctional inhibitors of e-selectin and galectin-3
PT110526B (pt) 2018-01-26 2021-02-04 Univ Nova De Lisboa Anticorpo, fragmento funcional ou sonda do mesmo contra antigénios tumorais
AU2019230013A1 (en) 2018-03-05 2020-09-10 Glycomimetics, Inc. Methods for treating acute myeloid leukemia and related conditions
BR112021004444A2 (pt) * 2018-09-10 2021-06-01 Cold Spring Harbor Laboratory métodos para tratar pancreatite
WO2020139962A1 (en) 2018-12-27 2020-07-02 Glycomimetics, Inc. Heterobifunctional inhibitors of e-selectin and galectin-3

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4342566A (en) * 1980-02-22 1982-08-03 Scripps Clinic & Research Foundation Solid phase anti-C3 assay for detection of immune complexes
US4965198A (en) * 1985-12-24 1990-10-23 Konica Corporation Monoclonal antibody and method of manufacturing hybridoma producing the same
US4949778A (en) * 1987-12-16 1990-08-21 Kawasaki Steel Corporation Immersion nozzle for continuous casting
DE4208795A1 (de) * 1992-03-19 1993-09-23 Behringwerke Ag Monoklonaler anti-gangliosid-antikoerper, seine herstellung und verwendung als tumortherapeutikum
US7682794B2 (en) * 2003-07-15 2010-03-23 The Regents Of The University Of California Methods for detecting and analyzing N-glycolylneuraminic acid (Neu5Gc) in biological materials
FI20055398A0 (sv) * 2005-07-08 2005-07-08 Suomen Punainen Risti Veripalv Förfarande för att evaluera cellpopulationer
WO2007054620A1 (en) * 2005-11-08 2007-05-18 Suomen Punainen Risti, Veripalvelu Novel carbohydrate profile compositions from human cells and methods for analysis and modification thereof
CA2692445A1 (en) * 2006-06-29 2008-01-03 Glykos Finland Oy Novel cellular glycan compositions
CA2712556A1 (en) * 2007-01-18 2008-07-24 Glykos Finland Ltd Novel carbohydrate from human cells and methods for analysis and modification thereof
US20100145032A1 (en) * 2007-01-18 2010-06-10 Suomen Punainen Risti, Veripalelu Novel carbohydrate profile compositions from human cells and methods for analysis and modification thereof
EP2115461A4 (en) * 2007-01-18 2010-01-13 Suomen Punainen Risti Veripalv NEW SPECIFIC CELL BINDING AGENTS

Also Published As

Publication number Publication date
EP2209809A1 (en) 2010-07-28
EP2209809A4 (en) 2011-03-30
CA2743032A1 (en) 2009-05-14
WO2009060129A1 (en) 2009-05-14
US20100292095A1 (en) 2010-11-18
JP2011504099A (ja) 2011-02-03
AU2008324073A1 (en) 2009-05-14

Similar Documents

Publication Publication Date Title
FI20070853A0 (sv) Glykanbindande monoklonala antikroppar
CY2019004I1 (el) Τροποποιημενα αντισωματα αντι-ιl-23ρ19
LTPA2018017I1 (lt) Žmogaus CGRP receptorių rišantys antikūnai
PL2178921T3 (pl) Monoklonalne przeciwciała przeciwko glipikanowi-3
IL234081B (en) Antibody binds cd3–epsilon in different species
BRPI0809677A2 (pt) Anticorpos anti-ige
BRPI0821777A2 (pt) Anticorpos biespecíficos bivalentes
SMT201700083B (it) Anticorpi monoclonali
DK2131860T3 (da) Anti-sclerostin-antistoffer
ZA201000049B (en) Monoclonal antibeta amyloid antibody
IL201340A (en) Antidote 3dc - epsilon in various species
EP2331579A4 (en) MONOCLONAL ANTIBODIES
DK2066695T3 (da) Anti-myostatin-antistoffer
BRPI0821405A2 (pt) Anticorpos biespecíficos, bivalentes
BRPI0821375A2 (pt) Anticorpos biespecíficos, bivalentes
BRPI0907532A2 (pt) Anticorpos anti-c5ar humanizados
IL200168A0 (en) Monoclonal anti-cxcl13 antibodies
ZA201004133B (en) Antigen binding proteins
CR20170001A (es) Anticuerpos anti factor d humanizados
NO344963B1 (no) Humanisert antistoff
BRPI0906877A2 (pt) Anticorpos anti-trkb aperfeiçoados
BRPI0820073A2 (pt) Anticorpos anti-axl
FI20075278A0 (sv) Nya fullständigt humana anti-VAP-1 monoklonala antikroppar
SG10201601279SA (en) Monoclonal Antibody STRO-4
BRPI0807991A2 (pt) Anticorpos anti-il-23r elaborados.

Legal Events

Date Code Title Description
FA Application withdrawn